Michel is currently responsible for CMC and Clinical Supply at NOEMA Pharma, developing new central nervous system (CNS) therapies.
He is responsible for a portfolio covering 4 molecules and 6 ongoing trials Phase 2 a & b and entry into Phase3.
Michel has over 25 years of experience in Pharmaceutical Development, Manufacturing and Supply, at Roche, Aventis and in Biotech Start-ups.
Michel is a Chemical Engineer and holds an MBA from INSEAD.
Jamie Myers is a skilled and experienced pharmacist with a strong background in clinical research and inpatient hospital pharmacy operations. With a Pharm.D. from Saint Louis College of Pharmacy and a PGY-1 Residency from Duke University Medical Center, Jamie has a solid foundation in pharmaceutical knowledge and patient care.
Currently serving as Senior Manager of Global Clinical Supply Chain at Takeda, Jamie oversees the coordination and management of investigational oncology medication for phase I/2 research studies. Prior to this role, Jamie worked as a Clinical Research Pharmacist Specialist at Brigham and Women’s/Dana Farber Inpatient Hospital. There, she worked for investigational drug services and dispensed research medications for therapeutic areas like critical care, emergency room, oncology, neurology, dermatology, and rheumatoid arthritis. Jamie gained first-hand experience with gene therapy, viral vectors, and COVID-19 vaccines, and was involved in the design and implementation of clinical research studies.
Before joining Mass General Brigham, Jamie served as a Clinical Coordinator for Drug Trials at Maine Medical Center, where she handled both clinical research and pharmacy responsibilities. Jamie was responsible for dispensing, accountability, and advising for phase II through IV studies, and worked closely with CRAs for site evaluations, audits, and closeouts.
Jamie’s career also includes experience as a Pharmacy Operations Manager at Winchester Hospital and as a Medical Science Liaison (Clinical Science Manager) at Abbott. She has been involved in accelerated oncology programs, served as a preceptor for fellowship programs, and has been recognized as a subject matter expert in temperature excursions. Jamie has also contributed to various publications and research studies in the field of pharmacy.
With a strong commitment to patient care and research excellence, Jamie has demonstrated her ability to effectively manage clinical trials, collaborate with multidisciplinary teams, and ensure the highest standards of pharmaceutical care.
Gilad Beck serves as the Natick, MA Site Head, Operations and Manufacturing Director at Orgenesis. He holds a BSc in Biotechnology and has over 10 years of experience working in the cell and gene therapy industry, in leading manufacturing, process development and project management roles. His background includes extensive knowledge of various cell and gene therapy processes, process development, tech transfer, closed and automated systems and GMP operations. Mr. Beck is also an expert in building cross-functional high performing teams. He utilizes his skills and experience to lead the Natick, MA site set up and operations as part of Orgenesis’ POCare Network that brings together patients, doctors, industry partners, research institutes and hospitals worldwide to achieve harmonized, regulated clinical development and production of life-saving therapies.
Rakib Ouro-Djobo is an empowering servant and a dedicated supply chain management leader focused on providing global access to life-saving treatments and life-changing opportunities. He has over 12 years of experience supporting mission-driven organizations in the life science and biotech industries. Currently, he works as the Clinical Supply Chain Lead for the Bill & Melinda Gates Medical Research Institute.
Sarah Mandlebaum is a dedicated sustainability professional serving as the Lead for Global Environmental Sustainability & Life Cycle Assessment at Takeda in Lexington, Massachusetts. With a strong foundation in sustainability, she currently leads Takeda’s work around measuring the sustainability performance of Takeda’s products. Sarah holds a Master of Business Administration (MBA) from the Yale School of Management and a Master of Public Health (MPH) in Environmental Health from the University of Michigan.
Jessica Vieira, PhD, leads the global value chain environmental sustainability strategy at Takeda Pharmaceutical Company. She has a decade of experience in environmental sustainability strategy across the chemical, consumer electronics and food technology industries and holds a PhD focused on life cycle assessment as well as a background in environmental engineering. In her role at Takeda, Jessica leads the Scope 3 greenhouse gas emissions reduction program aimed at achievement of the company’s goal to reach net-zero across the value chain before 2040.
Sydney Reynolds, PharmD, MS, is the First Year Global Clinical Supply Chain Fellow at Takeda. Sydney graduated in May of 2023 from The Ohio State University College of Pharmacy with her PharmD and MS in Translational Pharmacology specializing in Clinical Pharmacology and Clinical Trial Design. Before that, she received her BS in Chemistry and Biology from the University of Indianapolis. Throughout pharmacy school, she was a Clinical Pharmacy Intern at The OSU James Cancer Hospital, where she was also heavily involved in research. She held leadership positions in Student College of Clinical Pharmacy (SCCP) and was a PharmD Ambassador for the college. For Sydney, pharmaceutical research is where her two passions collide – science and healthcare. She is excited to jumpstart her career with her fellowship and begin improving the lives of patients in the biopharmaceutical industry.
Anthony has worked for the FDA since April of 2010 as an investigator in the BIMO, Foods and now import program area’s.
Swathi is an experienced and successful leader with over 12 years of Pharmaceutical, Biologics, and Medical Device experience specializing in submissions to global health authorities. She has led large diverse teams to ensure regulatory submission success from investigational, marketing, and post-marketing submissions. Swathi holds a Master of Science degree in Regulatory Affairs, as well as RA Certifications from RAPS in both the US and EU. With a unique combination of Regulatory Affairs and submissions experience, she drives the teams with best practices for methodical planning, efficient development, and management of multi-country dossiers.